A b s t r a c t
Placental mesenchymal dysplasia (PMD) is a rare condition of placentomegaly and abnormal chorionic villi often clinically mistakenly as partial hydatidiform mole. However, it is clinicopathologically distinct with high incidence of intrauterine growth restriction (IUGR) and fetal death. This study presents 11 new PMD cases and provides a meta-analysis of the associated IUGR and fetal death rates. The cases were identified between 1971 and 2005, mostly from consultation files. To our knowledge, 71 PMD cases have previously been reported; 15 of these were associated with Beckwith-Wiedemann syndrome (BWS). With the addition of our new results, among all cases without BWS, 50% had IUGR and 43% had intrauterine fetal demise (IUFD) or neonatal death. Females represented 82% of cases. Thus, PMD is associated with high IUGR and IUFD/neonatal death rates and disproportionally affects females. The pathogenesis is yet unknown. The current understanding and hypotheses involving PMD are discussed.
First described in 1991 by Moscoso and colleagues, 1 placental mesenchymal dysplasia (PMD) is a rare lesion. Sonographically, PMD shows findings similar to those of partial hydatidiform mole, such as enlarged placentas with multicystic, anechoic regions (giving a moth-eaten appearance [2] [3] [4] [5] [6] ), and widely distributed, large, edematous villi as seen under gross examination. PMD has distinct clinicopathologic features. Unlike molar pregnancies, characterized by absent or malformed fetuses, PMD usually features a normal fetus and the pregnancy often extends into the third trimester. About 20% of the fetuses with PMD also have Beckwith-Wiedemann syndrome (BWS), a condition characterized by macrosomia, visceromegaly, hemihyperplasia (hemihypertrophy), macroglossia, omphalocele, and adrenal cytomegaly that is recognizable prenatally or in infancy. It is unknown whether cases with BWS are distinct from cases without BWS; however, their placental findings are morphologically similar.
In previous case reports and small series, intrauterine growth restriction (IUGR) and intrauterine fetal demise (IUFD) often were noted. The purposes of this article are to describe 11 new cases and to review the literature with attention to the rates of associated IUGR and IUFD in PMD.
Materials and Methods
Eleven cases of PMD were identified between January 1971 and September 2005. One case was received internally at the University of California, San Diego. The rest were received from outside institutions for consultation. Clinical data were obtained from pathology reports and patient records.
Results

Clinical Findings
We examined 11 new cases of PMD ❚Table 1❚. (No clinical or gross placental data were available for case 11.) Maternal ages ranged from 22 to 33 years. Except for case 1 with preeclampsia, the available maternal history in all cases was noncontributory; however, detailed medical histories were lacking with regard to the presence of thrombophilic states, such as antiphospholipid syndrome, genetic polymorphism for factor V, prothrombin, and methyltetrahydrofolate reductase (MTHFR), and autoimmune disorders. The gestational periods ranged from 30 to 37 weeks. In case 6, a transabdominal ultrasound study at 23 weeks' gestation showed a placenta with multiple 3-to 9-mm, hypoechoic cysts, suggestive of a partial hydatidiform mole ❚Image 1❚. The concurrent maternal serum β human chorionic gonadotropin level was normal (10,300 mIU/mL [10, unavailable for the other 6 cases. Based on available data, 6 fetuses had IUGR, and 4 of these were stillborn. No fetuses or newborns had BWS. One fetus (case 2) had a congenital hepatic mesenchymal hamartoma as noted in a pathology report. The histologic slides of this lesion were not available for review.
Gross and Histologic Findings
The average unfixed placental weight was 863 g (2.31 multiples of median [MoM] ; normal medians referenced from established report). 9 The weight of the placenta in case 3 was obtained after formalin fixation; as such, the actual unfixed weight likely was lighter than the apparent weight (approximately 8% lighter). 10 Four cases had abnormal umbilical cords, including a tortuous and markedly right-twisted cord, an excessively long cord with marked left twist, a single-artery umbilical cord, and a cord with furcate (branched) insertion. Varicose dilation of fetal chorionic vessels was present in all cases ❚Image 2❚. Cut surfaces showed heterogeneous areas of abnormal tan and gelatinous and normal red-brown and spongy villous tissues ❚Image 3❚. The dysplastic tissue constituted up to 80% of the placental volume. Focal infarcts and intervillous thrombi were noted.
Surface vessels were markedly dilated, up to 3.0 cm in diameter, and thrombosed. The vascular walls were markedly stretched and extensively degenerated. In some cases, transmural medial necrosis was noted ❚Image 4❚. Intimal cushions with fibrous organization were found in all cases. Many vessels had endothelial damage, hemorrhage into the vessel wall, and fibroblastic organization. These changes have been described by Sander 11 as "hemorrhagic endovasculitis" and by Redline et al 12 as "villous stromal-vascular karyorrhexis." These changes were found most often in cases with IUFD. Villous chorangiosis (hypercapillarization), defined as more than 10 terminal villi showing 10 or more capillaries per villus, was identified in several areas within a placenta or more diffusely throughout the placental parenchyma uninvolved by dysplastic changes. 13 A 5-cm capillary chorioangioma was present in case 5 (Image 4D).
The placental parenchyma showed typical features of PMD. The stem villi were abnormally enlarged and often surrounded by excessive fibrinoid material. They consisted of a myxofibroblastic proliferation of spindle and stellate mesenchymal cells without cytologic atypia or prominent mitotic activity ❚Image 5A❚, ❚Image 5B❚, ❚Image 5C❚, and ❚Image 5D❚. The abundant extracellular matrix supporting the cells consisted primarily of hyaluronic acid, as demonstrated by a loss of alcian blue staining after hyaluronidase digestion. Villous stromal cystic degeneration, forming cisterns simulating those in molar villi, was present focally. Trophoblastic hyperplasia and inclusions were absent. Central thick-walled blood vessels with constricted lumens and scattered peripheral small capillaries were observed. Some vessels were thrombosed with recanalization. The residual normal placental villi showed maturation consistent with gestational ages. Excessive numbers of nucleated RBCs were identified in cases 3, 5, 7, and 9.
Immunohistochemical Findings
Immunohistochemically, stromal cells of normal and dysplastic villi were immunoreactive for desmin, similar to findings for an age-matched normal placenta. However, dysplastic villi were negative for smooth muscle actin, whereas normal villi were positive ❚Image 5E❚ and ❚Image 5F❚. There was no detectable Ki-67 or Flk-1 protein expression in either tissue. DNA ploidy analysis of the abnormal villi in case 5 demonstrated normal diploid constituency. Similarly, the abnormal villi in case 6 had a normal 46,XX karyotype, in accordance with the corresponding amniotic fluid.
Meta-analysis of IUGR and IUFD
Including the present cases, 82 cases of PMD have been reported ❚Table 2❚. [1] [2] [3] [4] [5] [6] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Of these cases, 15 were associated with an established or a probable diagnosis of BWS. Fetuses with BWS generally were larger than those without (mean ± SD, 79th ± 19th percentile vs 25th ± 26th percentile; P < .0001) ❚Figure 1❚. Similarly, fetuses with BWS had larger placentas than those without (mean ± SD, 3.9 ± 1.6 MoM vs 2.6 ± 1.3 MoM; P < .0093; normal placental weights referenced from established report). 9 Cases associated with BWS were excluded from the following analyses. Birth weight data and fetal outcome were available for 46 and 59 cases, respectively. The IUGR rate was 50% (23/46). The IUFD and neonatal death rates were 36% (21/59) and 7% (4/59), respectively. Of the deaths, 56% were not associated with IUGR (14 deaths without IUGR vs 11 deaths with concomitant IUGR). Females represented 82% (46/56) of the affected fetuses.
Discussion
To date, a total of 82 PMD cases have been reported (Tables 1 and 2 ). Paradinas et al 25 estimated the rate of 1 PMD in 500 cases referred for probable molar pregnancies. Arizawa and Nakayama 14 calculated an incidence of 0.02% of placentas examined at the Osaka Medical Center and Research Institute for Maternal and Child Health. We present the third largest series of PMD. Other than 5 cases with preeclampsia and 1 with placenta previa, no significant maternal illnesses were reported in association with PMD. However, the common presence of chorionic vessel thrombosis raises the question of whether there might have been cryptic maternal thrombophilia.
A high rate of IUGR is found in the meta-analysis of all cases reported to date. Of fetuses without BWS, 50% were growth restricted; many weighed less than the 5th percentile. Similarly, a high rate of fetal and neonatal death was found; about 40% of affected fetuses and neonates died prematurely. Many of them did not have IUGR, implying that factors other than growth restriction contributed to their demise. IUGR and fetal death are caused by a variety of genetic and environmental insults. [31] [32] [33] [34] Maternal causes include various thrombophilias such as antiphospholipid syndrome, MTHFR, prothrombin and factor V mutations, and systemic lupus erythematosus. Maternal illness, such as hypertension and diabetes mellitus, and narcotic drug use also contribute to fetal morbidity and mortality. Fetal causes include numeric and structural chromosomal abnormalities. The placenta has a significant role in the health of the fetus because it is the sole source of nutrients for the fetus and is the first line of defense from the external world. Many placental diseases, including large chorioangiomas (8-17 cm in greatest dimension), maternal and fetal vascular thrombosis, maternal floor infarction, infection, and umbilical cord abnormalities, result in fetal growth restriction and even fetal death. 35, 36 In cases of PMD, IUGR and IUFD may be explained by a potentially chronic hypoxia secondary to obstructive fetal vascular thrombosis and decreased maternal-fetal gas exchange due to an insufficient amount of normal chorionic villi and shunting of blood from the exchange surface in chorioangiomas and dysplastic villi. The long-term sequelae in infants with PMD are unknown, and thorough clinical follow-up was unavailable in most cases. Anecdotally, in the present case 8, the infant was found to have delayed expressive language skills at 26 months of age. Although the cause of subtle neurologic abnormalities was difficult to discern, intrauterine insufficiency represented a possible cause, especially when the insults occurred early in development and were persistent. A significant correlation between cerebral palsy and severe placental vascular lesions, including thrombosis, has been identified. 37, 38 One prominent feature of PMD is thrombosed chorionic vessels. Sander 28 has shown that arteries and veins are affected. The marked dilation of these vessels may have caused significant distortion of the vascular channels and altered the flow dynamics, leading to endothelial injury and thrombosis. Curiously, 4 cases in this series showed umbilical cord anomalies, ie, furcate insertion, marked twisting, excessive length, and a single umbilical artery. Unfortunately, umbilical cord findings were not described in most previous cases of PMD. The exceptions were 1 case with velamentous insertion, 1 with a single umbilical artery, and 2 cases with excessively long cords. 2, 3, 22, 28 It is possible that abnormal umbilical cords may contribute to the vascular anomalies in PMD. Redline 39 noted that 16 of 23 placentas with fetal thrombotic vasculopathy, a placental pathology somewhat related to PMD by the presence of placental vascular thrombosis, had umbilical cord abnormalities, including marginal insertion and hypercoiling. Umbilical cord defects can cause complete obstruction of venous return and lead to fetal death. Hypothetically, if the cord problems are sublethal and persisting, the resulting fetal hypoxia may stimulate placental remodeling such as hypervascularity (chorangiosis and chorioangiomas), increased erythropoiesis (excessive number of nucleated RBCs), and stromal hyperplasia (dysplastic villi).
Immunohistochemical stains were used to study cellular differentiation and tissue vascularity. Normal and dysplastic villi were immunoreactive for desmin. However, with respect to smooth muscle actin, the normal villi were positive, but the dysplastic villi were negative, possibly owing to arrested differentiation. These findings confirm and extend the only other report on desmin and smooth muscle actin expression in PMD. 24 Additional molecular and ultrastructural studies may provide further insights. With respect to tissue vascularity, the frequently observed chorangiosis in PMD might be attributable to the overexpression of VEGF receptors. To start investigating this hypothesis, we stained for one of the high-affinity receptors of VEGF, Flk-1, and found that it was not overexpressed. Further studies with VEGF and other VEGF receptors will clarify their roles in PMD. Furthermore, the dysplastic villi in PMD did not have a high proliferative rate, as demonstrated by lack of Ki-67 expression. The pathogenesis of PMD is unclear. Most cases of PMD had abnormal ultrasound results with an impression of partial hydatidiform moles in the second or third trimester. Although PMD may mimic partial molar pregnancy sonographically and by gross examination, a key difference between partial molar and normal placentas is their genetic composition. Partial hydatidiform moles are 70% to 80% triploid, often with 2 sets of paternal genes and 1 of maternal genes as a result of dispermy fertilization. 40, 41 In PMD, apparently normal karyotypes often were found.
The genetic constituency of these cases is controversial. Previous reports indicated normal biparental genetic constitution. For example, Chen et al 15 amplified 5 genetic marker loci by polymerase chain reaction in tissues from the fetus, both parents, a chorioangioma, and abnormal villi in their case 1 and showed that there was identical heterozygous biparental genetic composition in the fetus, the chorioangioma, and the abnormal villi. They also established genetic identity using the same technique in their case 2 in the fetus, the chorioangioma, and the abnormal villi. 15 Similarly, Hojberg et al 19 showed by restriction fragment length polymorphism analysis with 7 genetic loci that the abnormal villi, the normal villi, and the fetal membranes in their single case had identical, balanced, biparental contribution. However, recently, Cohen et al 16 described 3 cases with aneuploidy: a trisomy 13 with balanced translocation between chromosomes 1 and 13, a Klinefelter syndrome (47,XXY), and a triploid (69,XXX; a case previously reported by Paradinas et al 25 ) . It is possible that these rare aneuploid cases are coincidences.
Still, the genetic constituency of PMD is unsettled as Kaiser-Rogers et al 20 pointed out in their recent report. They described 2 cases in which androgenic/biparental mosaicism was identified in the PMD placentas by routine karyotype analysis, comparative genomic hybridization, and molecular microsatellite analysis. In their case 1, androgenic cells were identified in a mixture with biparental cells in the amniotic fluid, chorion, and mesenchyme but not the cord blood or trophoblast. In their case 2, androgenic cells were identified in chorion, chorionic vessel, and mesenchyme but not the umbilical cord, amnion, or trophoblast. The authors hypothesized that such mosaicism arose as the result of failure of the maternal genome to duplicate before the first cleavage with normal duplication and segregation of the paternal genome, resulting in 2 daughter cells, 1 with normal biparental genes and 1 with only paternal genes (23 chromosomes). The latter daughter cell became "diploid" through endoreduplication. The biparental cell presumably gave rise to the fetus, amnion, and trophoblast and the androgenic cell to a variable portion of chorion and villous mesenchyme with the altered morphologic features of PMD.
Indeed, this novel hypothesis also may account for the marked female predominance in PMD because an androgenic 46,YY cell line presumably is nonviable. In this sense, PMD may be related to a complete mole, which often is androgenic 46,XX. This novel finding of androgenic/biparental mosaicism in PMD deserves further exploration.
Although most cases of PMD are associated with completely normal fetuses, the finding of a few cases of PMD featuring congenital hemangiomas, vascular hamartomas, and hepatic mesenchymal hamartomas suggests that there is a common defect in the placental and embryonic mesoderms. 4, 15, 18 Kitano and colleagues 4 noted 3 hypotheses for the development of hepatic mesenchymal hamartomas: (1) a developmental anomaly arising from mesenchymal rest in the portal triad, (2) a reactive process to bile duct obstruction, and (3) a regional ischemia due to vascular thrombosis. While speculating that the hepatic mesenchymal hamartoma may be a part of a spectrum of congenital malformations of the mesoderm, the authors admitted that the relationship between hepatic mesenchymal hamartoma and PMD is unknown. Their co-occurrence may be completely coincidental. coexisting fetal malformation of any kind prevents a definitive conclusion about their relationship. Other investigators noted the similarity between PMD and chorioangiomas and hypothesized that an extraembryonic mesodermal defect was accountable for PMD associated with normal fetuses. 6, 28 A genetic mutation has not been described for PMD. However, the finding of PMD in fetuses with BWS suggests that there might be a genetic relationship. BWS is a condition of constitutional overgrowth with genetic linkage to chromosome 11p15.5. 42 The insulin-like growth factor-2 (IGF-2) is located in this region, and the maternal allele normally is suppressed so that only the paternal gene is expressed (maternal imprinting). Disruption of IGF-2 imprinting has been implicated in BWS, responsible for the overgrowth. 43 Because PMD is also a condition of overgrowth, imprinting of IGF-2 may have a role in its pathogenesis. 30 To that point, Chan and Sampson 2 reported a case of PMD with fetal tissue showing uniparental disomy of chromosome 11, the end results being similar to disruption of genetic imprinting. Confined placental mosaicism may explain the lack of fetal overgrowth in most cases.
The predominance of affected females also may offer a clue to the pathogenesis of PMD. Arizawa and Nakayama, 14 citing the work of Yamada et al, 44 pointed out that VEGF-D, related to angiogenesis, is located on the chromosome Xp22.31. They reported a case of PMD in a female fetus with deletion of the short arm of the X chromosome. The association between the X chromosome and PMD awaits clarification.
Conclusion
PMD is a rare and clinically significant lesion with high rates of IUGR, IUFD, and neonatal death. Female fetuses are affected disproportionately. Its cause and pathogenesis are unclear. However, promising results can be expected from molecular and genetic studies, relating this condition to genetic imprinting of chromosome 11p15, BWS, confined placental mosaicism, and other genetic mutations on chromosome X. Awareness of this entity-its sonographic similarity to partial hydatidiform mole, unique pathologic features, and high rate of IUFD-is important for prenatal counseling and monitoring. Given its association with BWS and IUGR, close postnatal monitoring also is warranted. Although a definitive association between acquired or inherited thrombophilia and PMD has not been identified, evaluation for such conditions may prove beneficial. As detailed in the preceding discussion, it is important to obtain fresh tissues from the placenta, the fetus, and both parents to advance this field of research. The cooperation among pathologist, neonatologist, and obstetrician will facilitate such acquisition. 
